ID   MOCH-1
AC   CVCL_5H94
DR   Wikidata; Q54906292
RX   PubMed=1377283;
RX   PubMed=7745612;
CC   Doubling time: ~2 days (PubMed=1377283).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2 MBP/c-neu transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
RX   PubMed=1377283; DOI=10.1002/jnr.490310123;
RA   Hayes C., Kelly D., Murayama S., Komiyama A., Suzuki K., Popko B.;
RT   "Expression of the neu oncogene under the transcriptional control of
RT   the myelin basic protein gene in transgenic mice: generation of
RT   transformed glial cells.";
RL   J. Neurosci. Res. 31:175-187(1992).
//
RX   PubMed=7745612; DOI=10.1002/jnr.490400207;
RA   Li Y., Atashi J.R., Hayes C., Reap E., Hunt S. 3rd, Popko B.;
RT   "Morphological and molecular response of the MOCH-1 oligodendrocyte
RT   cell line to serum and interferon-gamma: possible implications for
RT   demyelinating disorders.";
RL   J. Neurosci. Res. 40:189-198(1995).
//